PMV Pharmaceuticals

CRANBURY, NJ · Founded 2013 · CIK 0001699382 · Biotech · Public

Small molecule p53 regulators for cancer treatment

pmvpharma.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$74M
1 Form D · Mar 2017
115 months since last filing
Contracts
—
No federal contracts on record
Patents
40
12 granted · 28 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$73,728,198
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2223Alloy Therapeutics—$147M
2224ArriVent Biopharma—$191M
2225MOBIUS SCIENTIFIC INC.——
2226PMV Pharmaceuticals—$74M
2227FibroBiologics, LLC—$11M
2228Diagonal Therapeutics——
2229Nimbus Therapeutics——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 5 related persons
  • Arnold LevineDirector
  • David MackDirector · Executive Officer
  • Arnold OronskyDirector
  • Peter ThompsonDirector
  • Steve WinickDirector

Patents

USPTO · 12 granted of 40

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.